bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Figure S12 from Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition
Authors: Annala Matti , Taavitsainen Sinja , Khalaf Daniel J. , Vandekerkhove Gillian , Beja Kevin , Sipola Joonatan , Warner Evan W. , Herberts Cameron , Wong Amanda , Fu Simon , Finch Daygen L. , Oja Conrad D. , Vergidis Joanna , Zulfiqar Muhammad , Eigl Bernhard J. , Kollmansberger Christian K. , Nykter Matti , Gleave Martin E. , Chi Kim N. , Wyatt Alexander W.
Published: April 2023

Supplementary Figure S12 shows the re-detection rate for somatic mutations identified in an earlier cfDNA sample
Supplementary Figure S11 from Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition
Authors: Annala Matti , Taavitsainen Sinja , Khalaf Daniel J. , Vandekerkhove Gillian , Beja Kevin , Sipola Joonatan , Warner Evan W. , Herberts Cameron , Wong Amanda , Fu Simon , Finch Daygen L. , Oja Conrad D. , Vergidis Joanna , Zulfiqar Muhammad , Eigl Bernhard J. , Kollmansberger Christian K. , Nykter Matti , Gleave Martin E. , Chi Kim N. , Wyatt Alexander W.
Published: April 2023

Supplementary Figure S11 shows a comparison of the prognostic value of baseline circulating tumor DNA fraction versus a combined predictor based on all routine clinical variables
Figure S2 from Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion
Authors: Conforti Fabio , Pala Laura , Pagan Eleonora , Bagnardi Vincenzo , De Pas Tommaso , Queirolo Paola , Pennacchioli Elisabetta , Catania Chiara , Cocorocchio Emilia , Ferrucci Pier Francesco , Saponara Maristella , Orsolini Gianmarco , Zagami Paola , Nicoló Eleonora , De Marinis Filippo , Tortora Giampaolo , Bria Emilio , Minucci Saverio , Joffe Hadine , Veronesi Paolo , Wargo Jennifer , Rosenthal Rachel , Swanton Charles , Mantovani Alberto , Gelber Richard D. , Viale Giuseppe , Goldhirsch Aron , Giaccone Giuseppe
Published: April 2023

Supplementary Figure S2
Figure S1 from Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion
Authors: Conforti Fabio , Pala Laura , Pagan Eleonora , Bagnardi Vincenzo , De Pas Tommaso , Queirolo Paola , Pennacchioli Elisabetta , Catania Chiara , Cocorocchio Emilia , Ferrucci Pier Francesco , Saponara Maristella , Orsolini Gianmarco , Zagami Paola , Nicoló Eleonora , De Marinis Filippo , Tortora Giampaolo , Bria Emilio , Minucci Saverio , Joffe Hadine , Veronesi Paolo , Wargo Jennifer , Rosenthal Rachel , Swanton Charles , Mantovani Alberto , Gelber Richard D. , Viale Giuseppe , Goldhirsch Aron , Giaccone Giuseppe
Published: April 2023

Supplementary Figure S1
Table S1 from Abiraterone Acetate Induces CREB1 Phosphorylation and Enhances the Function of the CBP-p300 Complex, Leading to Resistance in Prostate Cancer Cells
Authors: Pan Wenting , Zhang Zhouwei , Kimball Hannah , Qu Fangfang , Berlind Kyler , Stopsack Konrad H. , Lee Gwo-Shu Mary , Choueiri Toni K. , Kantoff Philip W.
Published: April 2023

Table S1. Differential-express genes enrichment analysis in LNCaP-AAr and LNCaP.ES= enrichment score, NES= normalized enrichment score, NOM = nominal, FDR = false discovery rate. The significant related genes were defined with an NOM p-val less than 0.01 and FDR q-val less than 0.25.
Supplementary Fig. 4 from EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
Authors: Kandimalla Raju , Xu Jianfeng , Link Alexander , Matsuyama Takatoshi , Yamamura Kensuke , Parker M. Iqbal , Uetake Hiroyuki , Balaguer Francesc , Borazanci Erkut , Tsai Susan , Evans Douglas , Meltzer Stephen J. , Baba Hideo , Brand Randall , Von Hoff Daniel , Li Wei , Goel Ajay
Published: April 2023

Hierarchical clustering of CRC and healthy plasma samples
Supplementary Fig. 19 from EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
Authors: Kandimalla Raju , Xu Jianfeng , Link Alexander , Matsuyama Takatoshi , Yamamura Kensuke , Parker M. Iqbal , Uetake Hiroyuki , Balaguer Francesc , Borazanci Erkut , Tsai Susan , Evans Douglas , Meltzer Stephen J. , Baba Hideo , Brand Randall , Von Hoff Daniel , Li Wei , Goel Ajay
Published: April 2023

Multi-class (sec) prediction accuracy using various number of GI cancer-specific DMRs
Supplementary figure 1 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8+ T cells
Authors: Rijnders Maud , Balcioglu Hayri E. , Robbrecht Debbie G.J. , Oostvogels Astrid A.M. , Wijers Rebecca , Aarts Maureen J.B. , Hamberg Paul , van Leenders Geert J.L.H. , Nakauma-González J. Alberto , Voortman Jens , Westgeest Hans M. , Boormans Joost L. , de Wit Ronald , Lolkema Martijn P. , van der Veldt Astrid A.M. , Debets Reno
Published: April 2023

Study design
Table S5 from A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors
Authors: Shaikh Fyza Y. , White James R. , Gills Joell J. , Hakozaki Taiki , Richard Corentin , Routy Bertrand , Okuma Yusuke , Usyk Mykhaylo , Pandey Abhishek , Weber Jeffrey S. , Ahn Jiyoung , Lipson Evan J. , Naidoo Jarushka , Pardoll Drew M. , Sears Cynthia L.
Published: April 2023

Table S5
Table S4 from A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors
Authors: Shaikh Fyza Y. , White James R. , Gills Joell J. , Hakozaki Taiki , Richard Corentin , Routy Bertrand , Okuma Yusuke , Usyk Mykhaylo , Pandey Abhishek , Weber Jeffrey S. , Ahn Jiyoung , Lipson Evan J. , Naidoo Jarushka , Pardoll Drew M. , Sears Cynthia L.
Published: April 2023

Table S4
Supplementary Figure from Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer
Authors: Waks Adrienne G. , Kim Dewey , Jain Esha , Snow Craig , Kirkner Gregory J. , Rosenberg Shoshana M. , Oh Coyin , Poorvu Philip D. , Ruddy Kathryn J. , Tamimi Rulla M. , Peppercorn Jeffrey , Schapira Lidia , Borges Virginia F. , Come Steven E. , Brachtel Elena F. , Warner Ellen , Collins Laura C. , Partridge Ann H. , Wagle Nikhil
Published: April 2023

Supplementary Figure from Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer
Supplementary Data from A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors
Authors: Shaikh Fyza Y. , White James R. , Gills Joell J. , Hakozaki Taiki , Richard Corentin , Routy Bertrand , Okuma Yusuke , Usyk Mykhaylo , Pandey Abhishek , Weber Jeffrey S. , Ahn Jiyoung , Lipson Evan J. , Naidoo Jarushka , Pardoll Drew M. , Sears Cynthia L.
Published: April 2023

Supplemental figure and table legends
Figure S6 from A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors
Authors: Shaikh Fyza Y. , White James R. , Gills Joell J. , Hakozaki Taiki , Richard Corentin , Routy Bertrand , Okuma Yusuke , Usyk Mykhaylo , Pandey Abhishek , Weber Jeffrey S. , Ahn Jiyoung , Lipson Evan J. , Naidoo Jarushka , Pardoll Drew M. , Sears Cynthia L.
Published: April 2023

Figure S6. Differential abundance analysis of antibiotic resistance genes and virulence factors between R and NR for WGS datasets.
Figure S5 from A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors
Authors: Shaikh Fyza Y. , White James R. , Gills Joell J. , Hakozaki Taiki , Richard Corentin , Routy Bertrand , Okuma Yusuke , Usyk Mykhaylo , Pandey Abhishek , Weber Jeffrey S. , Ahn Jiyoung , Lipson Evan J. , Naidoo Jarushka , Pardoll Drew M. , Sears Cynthia L.
Published: April 2023

Figure S5. Limited gut microbiome compositional changes are observed during treatment with checkpoint inhibitors.
Figure S6 from Mucin Expression and Splicing Determine Novel Subtypes and Patient Mortality in Pancreatic Ductal Adenocarcinoma
Authors: Thompson Christopher M. , Cannon Andrew , West Sean , Ghersi Dario , Atri Pranita , Bhatia Rakesh , Smith Lynette , Rachagani Satyayanarayana , Wichman Christopher , Kumar Sushil , Batra Surinder K.
Published: April 2023

Cellularity-corrected expression of mucins and their impact on survival outcome in PDAC patients
Supplementary Figure S5 from A MET Targeting Antibody–Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer
Authors: Cazes Alex , Betancourt Oscar , Esparza Edgar , Mose Evangeline S. , Jaquish Dawn , Wong Eric , Wascher Alexis A. , Tiriac Hervé , Gymnopoulos Marco , Lowy Andrew M.
Published: April 2023

Post-treatment tumor volumes of PDX1342 grafted tumors treated with TR1801-ADC and gemcitabine
Supplementary Data from Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
Authors: Stein Eytan M. , DeAngelo Daniel J. , Chromik Jörg , Chatterjee Manik , Bauer Sebastian , Lin Chia-Chi , Suarez Cristina , de Vos Filip , Steeghs Neeltje , Cassier Philippe A. , Tai David , Kiladjian Jean-Jacques , Yamamoto Noboru , Mous Rogier , Esteve Jordi , Minami Hironobu , Ferretti Stephane , Guerreiro Nelson , Meille Christophe , Radhakrishnan Rajkumar , Pereira Bernard , Mariconti Luisa , Halilovic Ensar , Fabre Claire , Carpio Cecilia
Published: April 2023

Supplementary Data from Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
Supplementary Figure 3 from Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis
Authors: Pizzamiglio Sara , Ciniselli Chiara Maura , Triulzi Tiziana , Gargiuli Chiara , De Cecco Loris , de Azambuja Evandro , Fumagalli Debora , Sotiriou Christos , Harbeck Nadia , Izquierdo Miguel , Nuciforo Paolo , Huober Jens , Cappelletti Vera , Cinieri Saverio , Piccart Martine , Daidone Maria Grazia , Pruneri Giancarlo , Colombo Mario Paolo , Tagliabue Elda , Verderio Paolo , Di Cosimo Serena
Published: April 2023

Supplementary Figure S3. Interaction between tumor infiltrating immune cells and treatment arm in the study cohort (n=226; 80 pCR). Red diamond and line indicate Odds Ratio (OR) and its 95% confidence interval (CI) in the combination arm; blue diamond and line indicate OR and its 95% CI in single agent arm (trastuzumab or lapatinib).
Table S6 from Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
Authors: Jin Ying , Chen Yamei , Tang Huarong , Hu Xiao , Hubert Shawna M. , Li Qian , Su Dan , Xu Haimiao , Fan Yun , Yu Xinmin , Chen Qixun , Liu Jinshi , Hong Wei , Xu Yujin , Deng Huan , Zhu Dapeng , Li Pansong , Gong Yuhua , Xia Xuefeng , Gay Carl M. , Zhang Jianjun , Chen Ming
Published: April 2023

Table S6
List of cancer genes.
Supplementary Figure 3 from Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer
Authors: Fountzilas Christos , Bajor David L. , Mukherjee Sarbajit , Saltzman Joel , Witkiewicz Agnieszka K. , Maguire Orla , Minderman Hans , Nambiar Ram , Rosenheck Hanna R. , Knudsen Erik S. , Muhitch Jason B. , Abrams Scott I. , Wang Chong , Hutson Alan D. , Attwood Kristopher , Hicks Karen A. , Jurcevic Jennifer A. , Kalinski Pawel , Iyer Renuka , Boland Patrick M.
Published: April 2023

Intratumoral NK cells (baseline) by change in tumor size (A) and change in CEA (B).
Supplementary Data from 18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition
Authors: Reeves Kirsten M. , Song Patrick N. , Angermeier Allyson , Manna Deborah Della , Li Yufeng , Wang Jianbo , Yang Eddy S. , Sorace Anna G. , Larimer Benjamin M.
Published: April 2023

Supplementary Data from 18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition
Figure S7 from Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer
Authors: Paracchini Lara , Beltrame Luca , Grassi Tommaso , Inglesi Alessia , Fruscio Robert , Landoni Fabio , Ippolito Davide , Delle Marchette Martina , Paderno Mariachiara , Adorni Marco , Jaconi Marta , Romualdi Chiara , D'Incalci Maurizio , Siravegna Giulia , Marchini Sergio
Published: April 2023

Genomic plots showing potential genes of interest in the 11q13.3 region (A), 19p13.11 region (B), and 19q13.42. The red square indicates the position of the region within the chromosomes. Coordinates refer to the hg38 genome assembly.
Table S5 from Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study
Authors: Delaidelli Alberto , Dunham Christopher , Santi Mariarita , Negri Gian Luca , Triscott Joanna , Zheludkova Olga , Golanov Andrey , Ryzhova Marina , Okonechnikov Konstantin , Schrimpf Daniel , Stichel Damian , Ellison David W. , von Deimling Andreas , Kool Marcel , Pfister Stefan M. , Ramaswamy Vijay , Korshunov Andrey , Taylor Michael D. , Sorensen Poul H.
Published: April 2023

Table S5
Table S1 from Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study
Authors: Delaidelli Alberto , Dunham Christopher , Santi Mariarita , Negri Gian Luca , Triscott Joanna , Zheludkova Olga , Golanov Andrey , Ryzhova Marina , Okonechnikov Konstantin , Schrimpf Daniel , Stichel Damian , Ellison David W. , von Deimling Andreas , Kool Marcel , Pfister Stefan M. , Ramaswamy Vijay , Korshunov Andrey , Taylor Michael D. , Sorensen Poul H.
Published: April 2023

Table S1
Supplementary table 3 from Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell Carcinoma
Authors: Cao Yue , Haring Catherine T. , Brummel Collin , Bhambhani Chandan , Aryal Madhava , Lee Choonik , Heft Neal Molly , Bhangale Apurva , Gu Wenjin , Casper Keith , Malloy Kelly , Sun Yilun , Shuman Andrew , Prince Mark E. , Spector Matthew E. , Chinn Steven , Shah Jennifer , Schonewolf Caitlin , McHugh Jonathan B. , Mills Ryan E. , Tewari Muneesh , Worden Francis P. , Swiecicki Paul L. , Mierzwa Michelle , Brenner J. Chad
Published: April 2023

Detailed summary of host genome somatic single nucleotide variations identified by targeted capture sequencing analysis of FFPE tumor specimens
Supplementary Figure Legends from A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas
Authors: Yu Shengnan , Wei Shiyou , Savani Milan , Lin Xiang , Du Kuang , Mender Ilgen , Siteni Silvia , Vasilopoulos Themistoklis , Reitman Zachary J. , Ku Yin , Wu Di , Liu Hao , Tian Meng , Chen Yaohui , Labrie Marilyne , Charbonneau Casey M. , Sugarman Eric , Bowie Michelle , Hariharan Seethalakshmi , Waitkus Matthew , Jiang Wen , McLendon Roger E. , Pan Edward , Khasraw Mustafa , Walsh Kyle M. , Lu Yiling , Herlyn Meenhard , Mills Gordon , Herbig Utz , Wei Zhi , Keir Stephen T. , Flaherty Keith , Liu Lunxu , Wu Kongming , Shay Jerry W. , Abdullah Kalil , Zhang Gao , Ashley David M.
Published: April 2023

Supplementary Figure Legends
Supplementary Figure S2 from Targeting Fc Receptor-Mediated Effects and the “Don't Eat Me” Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer
Authors: Tian Lei , Xu Bo , Teng Kun-Yu , Song Mihae , Zhu Zheng , Chen Yuqing , Wang Jing , Zhang Jianying , Feng Mingye , Kaur Balveen , Rodriguez Lorna , Caligiuri Michael A. , Yu Jianhua
Published: April 2023

The effect of αCD47-G1 on the expression of the genes markering macrophage polarization in vitro.
Supplementary Data - Table 1 from A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)
Authors: Flaig Thomas W. , Tangen Catherine M. , Daneshmand Siamak , Alva Ajjai , Lerner Seth P. , Lucia M. Scott , McConkey David J. , Theodorescu Dan , Goldkorn Amir , Milowsky Matthew I. , Bangs Rick , MacVicar Gary R. , Bastos Bruno R. , Fowles Jared S. , Gustafson Daniel L. , Plets Melissa , Thompson Ian M.
Published: April 2023

Supplemental Table 1. Calculation of individual drug scores for COXEN
Supplemental Figure 1 from A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)
Authors: Flaig Thomas W. , Tangen Catherine M. , Daneshmand Siamak , Alva Ajjai , Lerner Seth P. , Lucia M. Scott , McConkey David J. , Theodorescu Dan , Goldkorn Amir , Milowsky Matthew I. , Bangs Rick , MacVicar Gary R. , Bastos Bruno R. , Fowles Jared S. , Gustafson Daniel L. , Plets Melissa , Thompson Ian M.
Published: April 2023

COXEN Model development
Supplementary Figure from Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception
Authors: Hernandez Sharia , Parra Edwin Roger , Uraoka Naohiro , Tang Ximing , Shen Yu , Qiao Wei , Jiang Mei , Zhang Shanyu , Mino Barbara , Lu Wei , Pandurengan Renganayaki , Haymaker Cara , Affolter Kajsa , Scaife Courtney L. , Yip-Schneider Michele , Schmidt C. Max , Firpo Matthew A. , Mulvihill Sean J. , Koay Eugene J. , Wang Huamin , Wistuba Ignacio I. , Maitra Anirban , Solis Luisa M. , Sen Subrata
Published: April 2023

Supplementary Figure from Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception
Figure S1 from TAS-116 (Pimitespib), an Oral HSP90 Inhibitor, in Combination with Nivolumab in Patients with Colorectal Cancer and Other Solid Tumors: An Open-Label, Dose-Finding, and Expansion Phase Ib Trial (EPOC1704)
Authors: Kawazoe Akihito , Itahashi Kota , Yamamoto Noboru , Kotani Daisuke , Kuboki Yasutoshi , Taniguchi Hiroya , Harano Kenichi , Naito Yoichi , Suzuki Mitsuko , Fukutani Miki , Higuchi Tsukiko , Ikeno Takashi , Wakabayashi Masashi , Sato Akihiro , Koyama Shohei , Nishikawa Hiroyoshi , Shitara Kohei
Published: April 2023

Figure S1
Table S3 from Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti–PD-1 Therapy
Authors: Telli Melinda L. , Nagata Hiroshi , Wapnir Irene , Acharya Chaitanya R. , Zablotsky Kaitlin , Fox Bernard A. , Bifulco Carlo B. , Jensen Shawn M. , Ballesteros-Merino Carmen , Le Mai Hope , Pierce Robert H. , Browning Erica , Hermiz Reneta , Svenson Lauren , Bannavong Donna , Jaffe Kim , Sell Jendy , Foerter Kellie Malloy , Canton David A. , Twitty Christopher G. , Osada Takuya , Lyerly H. Kim , Crosby Erika J.
Published: April 2023

Table S3
Supplementary Table S2 from An Allogeneic Multiple Myeloma GM-CSF–Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete Remission
Authors: Biavati Luca , Huff Carol Ann , Ferguson Anna , Sidorski Amy , Stevens M. Amanda , Rudraraju Lakshmi , Zucchinetti Cristina , Ali Syed Abbas , Imus Philip , Gocke Christian B. , Gittelman Rachel M. , Johnson Sarah , Sanders Catherine , Vignali Marissa , Gandhi Anita , Ye Xiaobu , Noonan Kimberly A. , Borrello Ivan
Published: April 2023

Supplementary Table S2
Figure S2 from Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti–PD-1 Therapy
Authors: Telli Melinda L. , Nagata Hiroshi , Wapnir Irene , Acharya Chaitanya R. , Zablotsky Kaitlin , Fox Bernard A. , Bifulco Carlo B. , Jensen Shawn M. , Ballesteros-Merino Carmen , Le Mai Hope , Pierce Robert H. , Browning Erica , Hermiz Reneta , Svenson Lauren , Bannavong Donna , Jaffe Kim , Sell Jendy , Foerter Kellie Malloy , Canton David A. , Twitty Christopher G. , Osada Takuya , Lyerly H. Kim , Crosby Erika J.
Published: April 2023

Figure S2
Supplementary Table 5 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
Authors: Even Caroline , Wang Hung-Ming , Li Shau-Hsuan , Ngan Roger K-C , Dechaphunkul Arunee , Zhang Li , Yen Chia-Jui , Chan Po Chung , Chakrabandhu Somvilai , Ma Brigette B.Y. , Tanasanvimon Suebpong , Lee Victor H.F. , Lou Pei-Jen , Li Zujun , Spira Alexander I. , Sukari Ammar , Guigay Joël , McCune Steven , Gonzalez-Maffe Juan , Szpakowski Sebastian , Yao Yao , Liang Hongzi , Mataraza Jennifer , Séchaud Romain , Manenti Luigi , Lim Darren W-T.
Published: April 2023

Supplemental Table S5. Adverse events ({greater than or equal to} 15% incidence of all grades events in any of the patient treatment arms)
Supplementary Table 1 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
Authors: Even Caroline , Wang Hung-Ming , Li Shau-Hsuan , Ngan Roger K-C , Dechaphunkul Arunee , Zhang Li , Yen Chia-Jui , Chan Po Chung , Chakrabandhu Somvilai , Ma Brigette B.Y. , Tanasanvimon Suebpong , Lee Victor H.F. , Lou Pei-Jen , Li Zujun , Spira Alexander I. , Sukari Ammar , Guigay Joël , McCune Steven , Gonzalez-Maffe Juan , Szpakowski Sebastian , Yao Yao , Liang Hongzi , Mataraza Jennifer , Séchaud Romain , Manenti Luigi , Lim Darren W-T.
Published: April 2023

Supplemental Table S1. Patient disposition
Supplementary Data from Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal Adenocarcinomas
Authors: Wo Jennifer Y. , Clark Jeffrey W. , Eyler Christine E. , Mino-Kenudson Mari , Klempner Samuel J. , Allen Jill N. , Keane Florence K. , Parikh Aparna R. , Roeland Eric , Drapek Lorraine C. , Ryan David P. , Corcoran Ryan B. , Van Seventer Emily , Fetter Isobel J. , Shahzade Heather A. , Khandekar Melin J. , Lanuti Michael , Morse Christopher R. , Heist Rebecca S. , Ulysse Christine A. , Christopher Benjamin , Baglini Christian , Yeap Beow Y. , Mullen John T. , Hong Theodore S.
Published: April 2023

Supplemental Appendix 7: Paired pre- and post- treatment SNaPshot molecular profiling available for 11 patients.
Supplementary Data from The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer
Authors: Manca Paolo , Corallo Salvatore , Busico Adele , Lonardi Sara , Corti Francesca , Antoniotti Carlotta , Procaccio Letizia , Clavarezza Matteo , Smiroldo Valeria , Tomasello Gianluca , Murialdo Roberto , Sartore-Bianchi Andrea , Racca Patrizia , Pagani Filippo , Randon Giovanni , Martinetti Antonia , Sottotetti Elisa , Palermo Federica , Perrone Federica , Tamborini Elena , Prisciandaro Michele , Raimondi Alessandra , Di Bartolomeo Maria , Morano Federica , Pietrantonio Filippo
Published: April 2023

Suppl Fig 6
Supplementary Table 8 from Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy
Authors: Nguyen Cong Trung , Caruso Stefano , Maille Pascale , Beaufrère Aurélie , Augustin Jérémy , Favre Loetitia , Pujals Anaïs , Boulagnon-Rombi Camille , Rhaiem Rami , Amaddeo Giuliana , di Tommaso Luca , Luciani Alain , Regnault Hélène , Brustia Raffaele , Scatton Olivier , Charlotte Frédéric , Brochériou Isabelle , Sommacale Daniele , Soussan Patrick , Leroy Vincent , Laurent Alexis , Le Van Ky , Ta Van To , Trinh Hong Son , Tran Thi Lan , Gentien David , Rapinat Audrey , Nault Jean Charles , Allaire Manon , Mulé Sebastien , Zucman-Rossi Jessica , Pawlotsky Jean-Michel , Tournigand Christophe , Lafdil Fouad , Paradis Valérie , Calderaro Julien
Published: April 2023

Supplementary Table 8: Molecular alterations identified in cHCC-CCA
Supplementary Table 1 from Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer
Authors: Zhang Henan , Orme Jacob J. , Abraha Feven , Stish B.J. , Lowe Val J. , Lucien Fabrice , Tryggestad Erik J. , Bold Michael S. , Pagliaro Lance C. , Choo C. Richard , Brinkmann Debra H. , Iott Matthew J. , Davis Brian J. , Quevedo J. Fernando , Harmsen William S. , Costello Brian A. , Johnson Geoffrey B. , Nathan Mark A. , Olivier Kenneth R. , Pisansky Thomas M. , Kwon Eugene D. , Dong Haidong , Park Sean S.
Published: April 2023

Supplementary Table 1. PSA progression by number of sites treated. 1Kaplan-Meier method; 2Cox model; 3Logrank test; 4Wald Chi-Square test.
Supplementary Table 7 from Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy
Authors: Nguyen Cong Trung , Caruso Stefano , Maille Pascale , Beaufrère Aurélie , Augustin Jérémy , Favre Loetitia , Pujals Anaïs , Boulagnon-Rombi Camille , Rhaiem Rami , Amaddeo Giuliana , di Tommaso Luca , Luciani Alain , Regnault Hélène , Brustia Raffaele , Scatton Olivier , Charlotte Frédéric , Brochériou Isabelle , Sommacale Daniele , Soussan Patrick , Leroy Vincent , Laurent Alexis , Le Van Ky , Ta Van To , Trinh Hong Son , Tran Thi Lan , Gentien David , Rapinat Audrey , Nault Jean Charles , Allaire Manon , Mulé Sebastien , Zucman-Rossi Jessica , Pawlotsky Jean-Michel , Tournigand Christophe , Lafdil Fouad , Paradis Valérie , Calderaro Julien
Published: April 2023

Supplementary Table 7: Difference in gene expression between Immune Low 1 (IL1) and Immune Low 2 (IL2) subgroups in the validation dataset (n=20, Coulouarn et al. Carcinogenesis. 2012) (33).
Supplementary Figure 3 from Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer
Authors: Zhang Henan , Orme Jacob J. , Abraha Feven , Stish B.J. , Lowe Val J. , Lucien Fabrice , Tryggestad Erik J. , Bold Michael S. , Pagliaro Lance C. , Choo C. Richard , Brinkmann Debra H. , Iott Matthew J. , Davis Brian J. , Quevedo J. Fernando , Harmsen William S. , Costello Brian A. , Johnson Geoffrey B. , Nathan Mark A. , Olivier Kenneth R. , Pisansky Thomas M. , Kwon Eugene D. , Dong Haidong , Park Sean S.
Published: April 2023

Supplementary Figure 3. Changes in CD8+CD11ahigh populations from baseline to days 1, 7, and 14.
Supplementary Table 6 from Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy
Authors: Nguyen Cong Trung , Caruso Stefano , Maille Pascale , Beaufrère Aurélie , Augustin Jérémy , Favre Loetitia , Pujals Anaïs , Boulagnon-Rombi Camille , Rhaiem Rami , Amaddeo Giuliana , di Tommaso Luca , Luciani Alain , Regnault Hélène , Brustia Raffaele , Scatton Olivier , Charlotte Frédéric , Brochériou Isabelle , Sommacale Daniele , Soussan Patrick , Leroy Vincent , Laurent Alexis , Le Van Ky , Ta Van To , Trinh Hong Son , Tran Thi Lan , Gentien David , Rapinat Audrey , Nault Jean Charles , Allaire Manon , Mulé Sebastien , Zucman-Rossi Jessica , Pawlotsky Jean-Michel , Tournigand Christophe , Lafdil Fouad , Paradis Valérie , Calderaro Julien
Published: April 2023

Supplementary Table 6: Difference in gene expression between Immune High 1 (IH1) and Immune High 2 (IH2) subgroups in the validation dataset (n=20, Coulouarn et al, Carcinogenesis, 2012) (33).
Figure_S4 from Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer
Authors: Westin Shannon N. , Labrie Marilyne , Litton Jennifer K. , Blucher Aurora , Fang Yong , Vellano Christopher P. , Marszalek Joseph R. , Feng Ningping , Ma XiaoYan , Creason Allison , Fellman Bryan , Yuan Ying , Lee Sanghoon , Kim Tae-Beom , Liu Jinsong , Chelariu-Raicu Anca , Chen Tsun Hsuan , Kabil Nashwa , Soliman Pamela T. , Frumovitz Michael , Schmeler Katheleen M. , Jazaeri Amir , Lu Karen H. , Murthy Rashmi , Meyer Larissa A. , Sun Charlotte C. , Sood Anil K. , Coleman Robert L. , Mills Gordon B.
Published: April 2023

Supplementary Figure S4
Supplementary Data from A Paradigm of Cancer Immunotherapy Based on 2-[18F]FDG and Anti–PD-L1 mAb Combination to Enhance the Antitumor Effect
Authors: Wen Xuejun , Shi Changrong , Zeng Xinying , Zhao Liang , Yao Lanlin , Liu Zhida , Feng Lixia , Zhang Deliang , Huang Jinxiong , Li Yesen , Lin Qin , Chen Haojun , Zhuang Rongqiang , Chen Xiaoyuan , Zhang Xianzhong , Guo Zhide
Published: April 2023

Supplementary Data from A Paradigm of Cancer Immunotherapy Based on 2-[18F]FDG and Anti–PD-L1 mAb Combination to Enhance the Antitumor Effect
Supplementary Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma
Authors: Wise-Draper Trisha M. , Gulati Shuchi , Palackdharry Sarah , Hinrichs Benjamin H. , Worden Francis P. , Old Matthew O. , Dunlap Neal E. , Kaczmar John M. , Patil Yash , Riaz Muhammed Kashif , Tang Alice , Mark Jonathan , Zender Chad , Gillenwater Ann M. , Bell Diana , Kurtzweil Nicky , Mathews Maria , Allen Casey L. , Mierzwa Michelle L. , Casper Keith , Jandarov Roman , Medvedovic Mario , Lee J. Jack , Harun Nusrat , Takiar Vinita , Gillison Maura
Published: April 2023

Supplementary Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma
Supplementary Table from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction
Authors: Zhu Mojun , Chen Chunhua , Foster Nathan R. , Hartley Christopher , Mounajjed Taofic , Salomao Marcela A. , Fruth Briant F. , Beamer Staci E. , Kim Yohan , Harrington Susan M. , Pitot Henry C. , Sanhueza Cristobal T. , Feng Yening , Herrmann Joerg , McWilliams Robert R. , Lucien Fabrice , Huang Bing Q. , Ma Wen Wee , Bekaii-Saab Tanios S. , Dong Haidong , Wigle Dennis , Ahn Daniel H. , Hallemeier Chris L. , Blackmon Shanda , Yoon Harry H.
Published: April 2023

Supplementary Table from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction
Supplementary Data from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy
Authors: Girardi Daniel M. , Niglio Scot A. , Mortazavi Amir , Nadal Rosa , Lara Primo , Pal Sumanta K. , Saraiya Biren , Cordes Lisa , Ley Lisa , Ortiz Olena Sierra , Cadena Jacqueline , Diaz Carlos , Bagheri Hadi , Redd Bernadette , Steinberg Seth M. , Costello Rene , Chan Keith S. , Lee Min-Jung , Lee Sunmin , Yu Yunkai , Gurram Sandeep , Chalfin Heather J. , Valera Vladimir , Figg William D. , Merino Maria , Toubaji Antoun , Streicher Howard , Wright John J. , Sharon Elad , Parnes Howard L. , Ning Yang-Min , Bottaro Donald P. , Cao Liang , Trepel Jane B. , Apolo Andrea B.
Published: April 2023

Supplementary Data from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy
Supplementary Data from First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Authors: Kim Tae Won , Burris Howard A. , de Miguel Luken Maria J. , Pishvaian Michael J. , Bang Yung-Jue , Gordon Michael , Awada Ahmad , Camidge D. Ross , Hodi F. Stephen , McArthur Grant A. , Miller Wilson H. , Cervantes Andres , Chow Laura Q. , Lesokhin Alexander M. , Rutten Annemie , Sznol Mario , Rishipathak Deepali , Chen Shang-Chiung , Stefanich Eric , Pourmohamad Tony , Anderson Maria , Kim Jeong , Huseni Mahrukh , Rhee Ina , Siu Lillian L.
Published: April 2023

Supplementary Data from First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Supplementary Table from Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma
Authors: Liu Jiayong , Gao Tian , Tan Zhichao , Li Shu , Xu Jie , Bai Chujie , Xue Ruifeng , Xie Lu , Zhang Lu , Fan Zhengfu , Guo Wei
Published: April 2023

Supplementary Table from Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma
Supplementary Data from Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma
Authors: Liu Jiayong , Gao Tian , Tan Zhichao , Li Shu , Xu Jie , Bai Chujie , Xue Ruifeng , Xie Lu , Zhang Lu , Fan Zhengfu , Guo Wei
Published: April 2023

Supplementary Data from Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma
Supplementary Figure from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Authors: Xu Junfen , Fang Yifeng , Chen Kelie , Li Sen , Tang Sangsang , Ren Yan , Cen Yixuan , Fei Weidong , Zhang Bo , Shen Yuanming , Lu Weiguo
Published: April 2023

Supplementary Figure from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Supplementary Data from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Authors: Xu Junfen , Fang Yifeng , Chen Kelie , Li Sen , Tang Sangsang , Ren Yan , Cen Yixuan , Fei Weidong , Zhang Bo , Shen Yuanming , Lu Weiguo
Published: April 2023

Supplementary Data from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Supplementary Table from Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
Authors: Chung Christine H. , Li Jiannong , Steuer Conor E. , Bhateja Priyanka , Johnson Matthew , Masannat Jude , Poole Maria I. , Song Feifei , Hernandez-Prera Juan C. , Molina Helen , Wenig Bruce M. , Kumar Sunil , Kuperwasser Charlotte , Stephens Philip J. , Farinhas Joaquim M. , Shin Dong M. , Kish Julie A. , Muzaffar Jameel , Kirtane Kedar , Rocco James W. , Schell Michael J. , Saba Nabil F. , Bonomi Marcelo
Published: April 2023

Supplementary Table from Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
Supplementary Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Authors: Nayak Lakshmi , Standifer Nathan , Dietrich Jorg , Clarke Jennifer L. , Dunn Gavin P. , Lim Michael , Cloughesy Timothy , Gan Hui K. , Flagg Elizabeth , George Elizabeth , Gaffey Sarah , Hayden Julia , Holcroft Christina , Wen Patrick Y. , Macri Mary , Park Andrew J. , Ricciardi Toni , Ryan Aileen , Schwarzenberger Paul , Venhaus Ralph , Reyes Melissa de los , Durham Nicholas M. , Creasy Todd , Huang Raymond Y. , Kaley Thomas , Reardon David A.
Published: April 2023

Supplementary Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Supplementary Data from Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors
Authors: Davar Diwakar , Zappasodi Roberta , Wang Hong , Naik Girish S. , Sato Takami , Bauer Todd , Bajor David , Rixe Olivier , Newman Walter , Qi Jingjing , Holland Aliya , Wong Phillip , Sifferlen Lianna , Piper Diane , Sirard Cynthia A. , Merghoub Taha , Wolchok Jedd D. , Luke Jason J.
Published: April 2023

Supplementary Data from Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors
Supplementary Data from Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer
Authors: Blenman Kim R.M. , Marczyk Michal , Karn Thomas , Qing Tao , Li Xiaotong , Gunasekharan Vignesh , Yaghoobi Vesal , Bai Yalai , Ibrahim Eiman Y. , Park Tristen , Silber Andrea , Wolf Denise M. , Reisenbichler Emily , Denkert Carsten , Sinn Bruno V. , Rozenblit Mariya , Foldi Julia , Rimm David L. , Loibl Sibylle , Pusztai Lajos
Published: April 2023

Supplementary Data from Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer
Supplementary Table from Safety and Efficacy of Irradiation Boost Based on 18F-FET-PET in Patients with Newly Diagnosed Glioblastoma
Authors: Harat Maciej , Blok Maciej , Miechowicz Izabela , Wiatrowska Izabela , Makarewicz Karolina , Małkowski Bogdan
Published: April 2023

Supplementary Table from Safety and Efficacy of Irradiation Boost Based on 18F-FET-PET in Patients with Newly Diagnosed Glioblastoma
Supplementary Figure from Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors
Authors: Chi Ping , Qin Li-Xuan , Camacho Niedzica , Kelly Ciara M. , D'Angelo Sandra P. , Dickson Mark A. , Gounder Mrinal M. , Keohan Mary L. , Movva Sujana , Nacev Benjamin A. , Rosenbaum Evan , Thornton Katherine A. , Crago Aimee M. , Francis Jasmine H. , Martindale Moriah , Phelan Haley T. , Biniakewitz Matthew D. , Lee Cindy J. , Singer Samuel , Hwang Sinchun , Berger Michael F. , Chen Yu , Antonescu Cristina R. , Tap William D.
Published: April 2023

Supplementary Figure from Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors
Supplementary Figure from Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
Authors: Lim Joline S.J. , Wong Andrea L.A. , Ow Samuel G.W. , Ngoi Natalie Y.L. , Chan Gloria H.J. , Ang Yvonne L.E. , Chong Wan Qin , Lim Siew Eng , Lim Yi Wan , Lee Matilda , Choo Joan R.E. , Tan Hon Lyn , Yong Wei Peng , Soo Ross A. , Tan David S.P. , Chee Cheng Ean , Sundar Raghav , Yadav Kritika , Jain Supriya , Wang Lingzhi , Tai Bee Choo , Goh Boon Cher , Lee Soo-Chin
Published: April 2023

Supplementary Figure from Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
Supplementary Data from Circulating Tumor DNA–Based MRD Assessment in Patients with CLL Treated with Obinutuzumab, Acalabrutinib, and Venetoclax
Authors: Fürstenau Moritz , Weiss Jonathan , Giza Adam , Franzen Fabian , Robrecht Sandra , Fink Anna-Maria , Fischer Kirsten , Schneider Christof , Tausch Eugen , Stilgenbauer Stephan , Ritgen Matthias , Schilhabel Anke , Brüggemann Monika , Eichhorst Barbara , Hallek Michael , Cramer Paula
Published: April 2023

Supplementary Data from Circulating Tumor DNA–Based MRD Assessment in Patients with CLL Treated with Obinutuzumab, Acalabrutinib, and Venetoclax
Supplementary Data from Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial
Authors: Draaisma Kaspar , Tesileanu C. Mircea S. , de Heer Iris , Klein Martin , Smits Marion , Reijneveld Jaap C. , Clement Paul M. , de Vos Filip Y.F. , Wick Antje , Mulholland Paul J. , Taphoorn Martin J.B. , Weller Michael , Chinot Olivier L. , Kros Johan M. , Verschuere Tina , Coens Corneel , Golfinopoulos Vassilis , Gorlia Thierry , Idbaih Ahmed , Robe Pierre A. , van den Bent Martin J. , French Pim J.
Published: April 2023

Supplementary Data from Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial
Supplementary Table from HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade Glioma
Authors: Sasame Jo , Ikegaya Naoki , Kawazu Masahito , Natsumeda Manabu , Hayashi Takahiro , Isoda Masataka , Satomi Kaishi , Tomiyama Arata , Oshima Akito , Honma Hirokuni , Miyake Yohei , Takabayashi Katsuhiro , Nakamura Taishi , Ueno Toshihide , Matsushita Yuko , Iwashita Hiromichi , Kanemaru Yu , Murata Hidetoshi , Ryo Akihide , Terashima Keita , Yamanaka Shoji , Fujii Yukihiko , Mano Hiroyuki , Komori Takashi , Ichimura Koichi , Cahill Daniel P. , Wakimoto Hiroaki , Yamamoto Tetsuya , Tateishi Kensuke
Published: April 2023

Supplementary Table from HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade Glioma
Supplementary Data from Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer
Authors: Sowalsky Adam G. , Figueiredo Ines , Lis Rosina T. , Coleman Ilsa , Gurel Bora , Bogdan Denisa , Yuan Wei , Russo Joshua W. , Bright John R. , Whitlock Nichelle C. , Trostel Shana Y. , Ku Anson T. , Patel Radhika A. , True Lawrence D. , Welti Jonathan , Jimenez-Vacas Juan M. , Rodrigues Daniel Nava , Riisnaes Ruth , Neeb Antje , Sprenger Cynthia T. , Swain Amanda , Wilkinson Scott , Karzai Fatima , Dahut William L. , Balk Steven P. , Corey Eva , Nelson Peter S. , Haffner Michael C. , Plymate Stephen R. , de Bono Johann S. , Sharp Adam
Published: April 2023

Supplementary Data from Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer
Supplementary Figure from Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements
Authors: Vougiouklakis Theodore , Zhu Kelsey , Vasudevaraja Varshini , Serrano Jonathan , Shen Guomiao , Linn Rebecca L. , Feng Xiaojun , Chiang Sarah , Barroeta Julieta E. , Thomas Kristen M. , Schwartz Lauren E. , Shukla Pratibha S. , Malpica Anais , Oliva Esther , Cotzia Paolo , DeLair Deborah F. , Snuderl Matija , Jour George
Published: April 2023

Supplementary Figure from Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements
Supplementary Data from Mechanistic Modeling of Central Nervous System Pharmacokinetics and Target Engagement of HER2 Tyrosine Kinase Inhibitors to Inform Treatment of Breast Cancer Brain Metastases
Authors: Li Jing , Jiang Jun , Bao Xun , Kumar Vineet , Alley Stephen C. , Peterson Scott , Lee Anthony J.
Published: April 2023

Supplementary Data from Mechanistic Modeling of Central Nervous System Pharmacokinetics and Target Engagement of HER2 Tyrosine Kinase Inhibitors to Inform Treatment of Breast Cancer Brain Metastases
Supplementary Data from BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma
Authors: Mehnert Janice M. , Mitchell Tara C. , Huang Alexander C. , Aleman Tomas S. , Kim Benjamin J. , Schuchter Lynn M. , Linette Gerald P. , Karakousis Giorgos C. , Mitnick Sheryl , Giles Lydia , Carberry Mary , Frey Noelle , Kossenkov Andrew , Groisberg Roman , Hernandez-Aya Leonel F. , Ansstas George , Silk Ann W. , Chandra Sunandana , Sosman Jeffrey A. , Gimotty Phyllis A. , Mick Rosemarie , Amaravadi Ravi K.
Published: April 2023

Supplementary Data from BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma
Supplementary Table from Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis
Authors: Palazón-Carrión Natalia , Martín García-Sancho Alejandro , Nogales-Fernández Esteban , Jiménez-Cortegana Carlos , Carnicero-González Fernando , Ríos-Herranz Eduardo , de la Cruz-Vicente Fátima , Rodríguez-García Guillermo , Fernández-Álvarez Rubén , Martínez-Banaclocha Natividad , Gumà-Padrò Josep , Gómez-Codina José , Salar-Silvestre Antonio , Rodríguez-Abreu Delvys , Gálvez-Carvajal Laura , Labrador Jorge , Guirado-Risueño María , García-Domínguez Daniel J. , Hontecillas-Prieto Lourdes , Espejo-García Pablo , Fernández-Román Isabel , Provencio-Pulla Mariano , Sánchez-Beato Margarita , Navarro Marta , Marylene Lejeune , Álvaro-Naranjo Tomás , Casanova-Espinosa Maria , Sánchez-Margalet Victor , Rueda-Domínguez Antonio , de la Cruz-Merino Luis
Published: April 2023

Supplementary Table from Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis
Supplementary Data from Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer
Authors: Deneka Alexander Y. , Baca Yasmine , Serebriiskii Ilya G. , Nicolas Emmanuelle , Parker Mitchell I. , Nguyen Theodore T. , Xiu Joanne , Korn W. Michael , Demeure Michael J. , Wise-Draper Trisha , Sukari Ammar , Burtness Barbara , Golemis Erica A.
Published: April 2023

Supplementary Data from Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer
Supplementary Data from An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors
Authors: Fucikova Jitka , Hensler Michal , Kasikova Lenka , Lanickova Tereza , Pasulka Josef , Rakova Jana , Drozenova Jana , Fredriksen Tessa , Hraska Marek , Hrnciarova Tereza , Sochorova Klara , Rozkova Daniela , Sojka Ludek , Dundr Pavel , Laco Jan , Brtnicky Tomas , Praznovec Ivan , Halaska Michael J. , Rob Lukas , Ryska Ales , Coosemans An , Vergote Ignace , Cibula David , Bartunkova Jirina , Galon Jérôme , Galluzzi Lorenzo , Spisek Radek
Published: April 2023

Supplementary Data from An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors
Supplementary Table from VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors – Efficacy, Safety, and Biomarker Results
Authors: Lindeman Geoffrey J. , Fernando Tharu M. , Bowen Rebecca , Jerzak Katarzyna J. , Song Xinni , Decker Thomas , Boyle Frances , McCune Steve , Armstrong Anne , Shannon Catherine , Bertelli Gianfilippo , Chang Ching-Wei , Desai Rupal , Gupta Kushagra , Wilson Timothy R. , Flechais Aulde , Bardia Aditya
Published: April 2023

Supplementary Table from VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors – Efficacy, Safety, and Biomarker Results
Supplementary Table from Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis
Authors: Berchuck Jacob E. , Baca Sylvan C. , McClure Heather M. , Korthauer Keegan , Tsai Harrison K. , Nuzzo Pier Vitale , Kelleher Kaitlin M. , He Monica , Steinharter John A. , Zacharia Soumya , Spisak Sandor , Seo Ji-Heui , Conteduca Vincenza , Elemento Olivier , Auh Joonghoon , Sigouros Michael , Corey Eva , Hirsch Michelle S. , Taplin Mary-Ellen , Choueiri Toni K. , Pomerantz Mark M. , Beltran Himisha , Freedman Matthew L.
Published: April 2023

Supplementary Table from Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis
Supplementary Data from Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma
Authors: Aragon-Sanabria Virginia , Aditya Anusha , Zhang Li , Chen Feng , Yoo Barney , Cao Tianye , Madajewski Brian , Lee Rachel , Turker Melik Z. , Ma Kai , Monette Sebastien , Chen Peiming , Wu Jing , Ruan Shutian , Overholtzer Michael , Zanzonico Pat , Rudin Charles M. , Brennan Cameron , Wiesner Ulrich , Bradbury Michelle S.
Published: April 2023

Supplementary Data from Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma